FDA clears Rcadias coronary artery assessment system
The FDA has granted Rcadia Medical Imaging’s latest COR Analyzer System 510(k) clearance, opening the way for Rcadia to release the third version of its coronary artery assessment software.

According to Rcadia, the newest clinical decision support system can now be used to detect stenotic lesions in coronary branch vessels, in addition to main arteries, in patients with suspected coronary artery disease undergoing CT angiography. Rcadia, which is headquartered in Auburndale, Mass., develops computer-aided detection programs, largely geared towards emergency use.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup